Duality Biotherapeutics, Inc. (HKG:9606)
Hong Kong · Delayed Price · Currency is HKD 315.60
+24.40 (8.38%)
At close: Mar 6, 2026
Duality Biotherapeutics Market Cap
Duality Biotherapeutics has a market cap or net worth of 26.25 billion as of March 6, 2026.
Market Cap
26.25B
Enterprise Value
22.26B
Revenue
2.38B
Ranking
n/a
PE Ratio
n/a
Stock Price
315.60
Market Cap Chart
Since April 15, 2025, Duality Biotherapeutics's market cap has increased from 17.51B to 26.25B, an increase of 49.87%. That is a compound annual growth rate of 57.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 26.25B | -1.56% |
| Dec 31, 2025 | 26.66B | 52.24% |
| Apr 15, 2025 | 17.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3SBio | 49.10B |
| Shanghai Henlius Biotech | 34.84B |
| Biocytogen Pharmaceuticals (Beijing) | 31.73B |
| Shanghai Junshi Biosciences | 30.65B |
| TransThera Sciences (Nanjing) | 24.22B |
| Genscript Biotech | 24.12B |
| PegBio | 23.43B |
| InnoCare Pharma | 22.46B |